AsiaBioNext is a strategic consulting and business development firm specialised in the biopharmaceutical sector, based in Singapore and operating in Asia.
AsiaBioNext mission is to help innovative biopharmaceutical companies exploring new horizons to grow and deliver their full potential at a global level.
AsiaBioNext provides operational and strategic consulting services to:
-innovative clinical and commercial stage biopharmaceutical companies from the United States and Europe for their strategic development in Asia, including cross-border strategic alliances
-innovative biopharmaceutical companies in Asia to expand to commercial stage and/or grow their business globally
-investment firms for the operational plans execution of their portfolio companies to accelerate value creation and global reach.
Company Details
- Founded
- -
- Address
- 43, Victoria Park Road, Singapore,singapore 266521,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Singapore, Singapore
Asiabionext Pte Ltd Questions
Asiabionext Pte Ltd's LinkedIn profile is https://sg.linkedin.com/company/asiabionext-pte-ltd
Asiabionext Pte Ltd's industry is
Biotechnology Research
Asiabionext Pte Ltd's top competitors are
Medison Pharma,
Innovacell Inc. / イノバセル株式会社,
Zhengzhou H&h Bioengineering Co., Ltd,
Diff Biotech,
Starter Cultures,
Etbio,
Odp Pharma,
Starter Culture,
M3 Global Technologies,
Kidswell Bio Corporation.
Asiabionext Pte Ltd's categories are Biotechnology Research
Asiabionext Pte Ltd's founding year is 2018
